Motexafin gadolinium

Jump to: navigation, search
Template:Chembox E number
Motexafin gadolinium
Identifiers
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
MeSH motexafin+gadolinium
Properties
C52H72GdN5O14
Molar mass 1148.4 g/mol
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

Motexafin gadolinium is an inhibitor of thioredoxin reductase and ribonucleotide reductase. It has been proposed as a possible chemotherapeutic agent in the treatment of brain cancer.[1]

References

  1. Richards G, Mehta M (2007). "Motexafin gadolinium in the treatment of brain metastases". Expert opinion on pharmacotherapy. 8 (3): 351–9. PMID 17266469.

Linked-in.jpg